山东大学学报 (医学版) ›› 2026, Vol. 64 ›› Issue (9): 78-87.doi: 10.6040/j.issn.1671-7554.0.2026.0289
汪筱涵1,2,3*,钟扬4,5*,陈浩4,5,种微1,2,3,邱成苗6,白浩5,6,吕明4,5,李乐平1,2,3
WANG Xiaohan1,2,3, ZHONG Yang4,5, CHEN Hao4,5, CHONG Wei1,2,3, QIU Chengmiao6, BAI Hao5,6, LYU Ming4,5, LI Leping1,2,3
摘要: 目的 探讨生命早期暴露因素及其加权风险评分与肠易激综合征(irritable bowel syndrome, IBS)发生风险之间的关联。 方法 纳入468 709例英国生物样本库参与者。通过基线问卷收集生命早期暴露数据,包括母乳喂养、母亲孕期吸烟、多胎出生、童年时期是否被领养以及出生体质量。以IBS为结局,采用多重插补法处理缺失协变量后,首先分别采用logistic回归模型评估各生命早期暴露因素与IBS发生风险的关联;随后将母乳喂养、母亲孕期吸烟、多胎出生及出生体质量纳入多变量logistic回归模型,依据模型β系数构建生命早期暴露因素风险评分,并评估该风险评分与IBS发生风险的关联。 结果 在完全调整协变量后研究结果显示,生命早期暴露因素包括非母乳喂养(OR=1.12, 95%CI: 1.08~1.15)、母亲孕期吸烟(OR=1.11, 95%CI: 1.08~1.14)及低出生体质量(OR=1.16, 95%CI: 1.03~1.32)与IBS发生风险增加相关。与生命早期暴露因素风险评分较低的参与者(最低四分位组,Q1)相比,生命早期暴露因素风险评分较高的参与者(第三至第四分位组,Q3~Q4),其IBS风险分别增加11%和19%(Q3: OR=1.11, 95%CI: 1.06~1.17; Q4: OR=1.19, 95%CI: 1.14~1.25)。 结论 较重的生命早期不良暴露负担(加权风险评分较高)与随后IBS发生风险增加相关。从生命历程流行病学角度提示,针对生命早期的公共卫生与健康促进策略可能对降低IBS的远期疾病负担具有积极意义,未来研究可致力于验证生命早期暴露因素与IBS之间的因果关系。
中图分类号:
| [1] Chen M J, Ruan G C, Chen L, et al. Neurotransmitter and intestinal interactions: focus on the microbiota-gut-brain axis in irritable bowel syndrome[J]. Front Endocrinol, 2022, 13: 817100. DOI:10.3389/fendo.2022.817100 [2] 高炼, 黄晓明, 吴清明. 肠易激综合征治疗与预防的研究进展[J]. 中国全科医学, 2022, 25(9): 1148-1154. Gao Lian, Huang Xiaoming, Wu Qingming. Recent developments in the prevention and treatment of irritable bowel syndrome[J]. Chinese General Practice, 2022, 25(9): 1148-1154. [3] Sperber A D, Bangdiwala S I, Drossman D A, et al. Worldwide prevalence and burden of functional gastrointestinal disorders, results of Rome foundation global study[J]. Gastroenterology, 2021, 160(1): 99-114.e3. [4] Oka P, Parr H, Barberio B, et al. Global prevalence of irritable bowel syndrome according to Rome III or IV criteria: a systematic review and meta-analysis[J]. Lancet Gastroenterol Hepatol, 2020, 5(10): 908-917. [5] Black C J, Ford A C. Global burden of irritable bowel syndrome: trends, predictions and risk factors[J]. Nat Rev Gastroenterol Hepatol, 2020, 17(8): 473-486. [6] Ying J C, Ye D, Luo P Y, et al. Lifestyle and genetic predisposition are associated with incident irritable bowel syndrome: a population-based prospective cohort study[J]. Clin Nutr, 2024, 43(6): 1544-1550. [7] Li X M, Yuan Q, Huang H, et al. Gut microbiota in irritable bowel syndrome: a narrative review of mechanisms and microbiome-based therapies[J]. Front Immunol, 2025, 16: 1695321. DOI:10.3389/fimmu.2025.1695321 [8] Li Y G, Liu S, Zhang Q, et al. Dietary index for gut microbiota and risk of incident irritable bowel syndrome: a large-scale prospective cohort study[J]. Nutr J, 2025, 24(1): 157. DOI:10.1186/s12937-025-01224-3 [9] Lenover Moyer M B, Jasani K, Waldman A B, et al. The developmental origins of irritable bowel syndrome: a systematic review and meta-analysis[J]. American J Hum Biol, 2025, 37: e24209. DOI:10.1002/ajhb.24209 [10] Mayer E A, Ryu H J, Bhatt R R. The neurobiology of irritable bowel syndrome[J]. Mol Psychiatry, 2023, 28(4): 1451-1465. [11] Parks C G, DAloisio A A, DeRoo L A, et al. Childhood socioeconomic factors and perinatal characteristics influence development of rheumatoid arthritis in adulthood[J]. Ann Rheum Dis, 2013, 72(3): 350-356. [12] Staines K A, Hardy R, Samvelyan H J, et al. Life course longitudinal growth and risk of knee osteoarthritis at age 53 years: evidence from the 1946 British birth cohort study[J]. Osteoarthr Cartil, 2021, 29(3): 335-340. [13] Luo L, Hee J Y, Zang S T, et al. Natural environmental factors at birth on risk for rheumatoid arthritis: the impact of season, temperature, latitude, and sunlight exposure[J]. BMC Public Health, 2025, 25(1): 1267. DOI:10.1186/s12889-025-22448-2 [14] Callaghan B L, Fields A, Gee D G, et al. Mind and gut: Associations between mood and gastrointestinal distress in children exposed to adversity[J]. Dev Psychopathol, 2020, 32(1): 309-328. [15] Sigvardsson I, Ludvigsson J, Andersson B, et al. Tobacco smoke exposure in early childhood and later risk of inflammatory bowel disease: a Scandinavian birth cohort study[J]. J Crohns Colitis, 2024, 18(5): 661-670. [16] Xu L, Lochhead P, Ko Y, et al. Systematic review with meta-analysis: breastfeeding and the risk of Crohns disease and ulcerative colitis[J]. Aliment Pharmacol Ther, 2017, 46(9): 780-789. [17] Bengtson M B, Aamodt G, Vatn M H, et al. Concordance for IBD among twins compared to ordinary siblings: a Norwegian population-based study[J]. J Crohns Colitis, 2010, 4(3): 312-318. [18] Koloski N A, Jones M, Weltman M, et al. Identification of early environmental risk factors for irritable bowel syndrome and dyspepsia[J]. Neurogastroenterology Motil, 2015, 27(9): 1317-1325. [19] Raslau D, Herrick L M, Locke G R, et al. Irritable bowel syndrome and the perinatal period: lower birth weight increases the risk[J]. Neurogastroenterology Motil, 2016, 28(10): 1518-1524. [20] Jacobs D R Jr, Woo J G, Sinaiko A R, et al. Childhood cardiovascular risk factors and adult cardiovascular events [J]. N Engl J Med, 2022, 386(20): 1877-1888. [21] Jia F, Sun J X, Liu X L, et al. Life Essentials 8 score and risk of metabolic syndrome: a dose-response analysis in the US population[J]. PLoS One, 2024, 19(10): e0312674. DOI:10.1371/journal.pone.0312674 [22] Wang R R, Shi M Y, Zhang Q L, et al. The association of early life factors with depression and anxiety in adults aged 40-69 years: a population-based cohort study[J]. Transl Psychiatry, 2024, 14: 299. DOI:10.1038/s41398-024-03006-7 [23] Watkins W J, Kotecha S J, Kotecha S. All-cause mortality of low birthweight infants in infancy, childhood, and adolescence: population study of England and Wales[J]. PLoS Med, 2016, 13(5): e1002018. DOI:10.1371/journal.pmed.1002018 [24] Said M A, Verweij N, van der Harst P. Associations of combined genetic and lifestyle risks with incident cardiovascular disease and diabetes in the UK biobank study[J]. JAMA Cardiol, 2018, 3(8): 693. DOI:10.1001/jamacardio.2018.1717 [25] Farrar D, Fairley L, Santorelli G, et al. Association between hyperglycaemia and adverse perinatal outcomes in south Asian and white British women: analysis of data from the Born in Bradford cohort[J]. Lancet Diabetes Endocrinol, 2015, 3(10): 795-804. [26] Bengtson M B, Rønning T, Vatn M H, et al. Irritable bowel syndrome in twins: genes and environment[J]. Gut, 2006, 55(12): 1754-1759. [27] Waehrens R, Li X J, Sundquist J, et al. Perinatal and familial risk factors for irritable bowel syndrome in a Swedish national cohort[J]. Scand J Gastroenterol, 2018, 53(5): 559-566. DOI:10.1080/00365521.2017.1398345 [28] Scarpato E, Salvatore S, Romano C, et al. Prevalence and risk factors of functional gastrointestinal disorders: a cross-sectional study in italian infants and young children [J]. J Pediatr Gastroenterol Nutr, 2023, 76(2): 27-35. [29] Farzaneh N, Ghobaklou M, Moghimi-Dehkordi B, et al. Effects of demographic factors, body mass index, alcohol drinking and smoking habits on irritable bowel syndrome: a case control study[J]. Ann Med Health Sci Res, 2013, 3(3): 391-396. [30] Kubo M, Fujiwara Y, Shiba M, et al. Differences between risk factors among irritable bowel syndrome subtypes in Japanese adults: Risk factors for IBS[J]. Neurogastroenterol Motil, 2011, 23(3): 249-254. [31] Ames S R, Lotoski L C, Azad M B. Comparing early life nutritional sources and human milk feeding practices: personalized and dynamic nutrition supports infant gut microbiome development and immune system maturation[J]. Gut Microbes, 2023, 15(1): 2190305. DOI:10.1080/19490976.2023.2190305 [32] Zhou G Q, Huang M J, Yu X, et al. Early life adverse exposures in irritable bowel syndrome: new insights and opportunities[J]. Front Pediatr, 2023, 11: 1241801. DOI:10.3389/fped.2023.1241801 [33] Yang J, Hou L L, Wang J F, et al. Unfavourable intrauterine environment contributes to abnormal gut micro-biome and metabolome in twins[J]. Gut, 2022, 71(12): 2451-2462. [34] Yuan Y, Wang X Y, Huang S, et al. Low-level inflammation, immunity, and brain-gut axis in IBS: unraveling the complex relationships[J]. Gut Microbes, 2023, 15(2): 2263209. DOI:10.1080/19490976.2023.2263209 [35] Falara E, Metallinou D, Nanou C, et al. Perinatal exposure to tobacco smoke and its association with the maternal and offspring microbiome: a systematic review[J]. Healthcare, 2024, 12(18): 1874. [36] Soufan F, Ghosson A, Jaber R, et al. The gut-brain axis in irritable bowel syndrome: implementing the role of microbiota and neuroimmune interaction in personalized prevention-a narrative review[J]. Health Sci Rep, 2025, 8(4): e70660. DOI:10.1002/hsr2.70660 [37] Purkiewicz A, Regin K J, Mumtaz W, et al. Breastfeeding: the multifaceted impact on child development and maternal well-being[J]. Nutrients, 2025, 17(8): 1326. DOI:10.3390/nu17081326 [38] Galley J D, Mashburn-Warren L, Blalock L C, et al. Maternal anxiety, depression and stress affects offspring gut microbiome diversity and bifidobacterial abundances[J]. Brain Behav Immun, 2023, 107: 253-264. [39] Shinohara S, Horiuchi S, Shinohara R, et al. Multiple pregnancy as a potential risk factor for postpartum depression: the japan environment and Childrens study[J]. J Affect Disord, 2023, 329: 218-224. [40] Egsgaard S, Bliddal M, Lund L C, et al. Risk and timing of postpartum depression in parents of twins compared to parents of singletons[J]. Acta Psychiatr Scand, 2025, 151(2): 163-172. [41] Yang D, Bai R L, Li C Z, et al. Early-life stress induced by neonatal maternal separation leads to intestinal 5-HT accumulation and causes intestinal dysfunction[J]. J Inflamm Res, 2024, 17: 8945-8964. [42] Rumbajan J M, Yamaguchi Y, Nakabayashi K, et al. The HUS1B promoter is hypomethylated in the placentas of low-birth-weight infants[J]. Gene, 2016, 583(2): 141-146. [43] Zhang Y, Liang J J, Liu Q, et al. Birth weight and adult obesity index in relation to the risk of hypertension: a prospective cohort study in the UK biobank[J]. Front Cardiovasc Med, 2021, 8: 637437. DOI:10.3389/fcvm.2021.637437 |
| [1] | 逄锦宏,苏萍,乔俊鹏,陈巧巧,陈学禹,赵颖颖,施婕,孙晓茹,李秋春,何蕊言,范轶欧,迟蔚蔚. 老年人群可改变心血管危险因素聚集模式与脑卒中的关联[J]. 山东大学学报 (医学版), 2025, 63(9): 11-19. |
| [2] | 王乐,罗清馨,吴思佳,吴雨桐,葛祎蕾,俞一凡,韦云,吉寒冰,刘铁梅,张紫妍,修佳伟,薛付忠,李洪凯. 虚弱和癫痫关联研究:前瞻性队列和孟德尔随机化分析[J]. 山东大学学报 (医学版), 2025, 63(9): 20-30. |
| [3] | 于晴晴,常开锋,李吉庆,张凯,付苹,刘晓雯,赵英淇,薛付忠. 中老年人群高血压在非甾体抗炎药暴露与心脑血管疾病风险关联中的中介分析[J]. 山东大学学报 (医学版), 2023, 61(8): 79-85. |
| [4] | 张凯,司书成,李吉庆,刘晓雯,赵英琪,薛付忠. 睡眠性状与肠易激综合征的孟德尔随机化研究[J]. 山东大学学报 (医学版), 2022, 60(8): 109-114. |
| [5] | 李竹青,张文雪,李理想,王鹏,于岩波,左秀丽,李延青. 丁酸钠下调IRAK1改善肠易激综合征内脏高敏感[J]. 山东大学学报 (医学版), 2018, 56(9): 23-28. |
| [6] | 张文雪,徐丽东,张明明,郭传国,左秀丽. NR2B通过mBDNF参与肠易激综合征内脏高敏感的发生[J]. 山东大学学报(医学版), 2017, 55(7): 17-22. |
| [7] | 李江冰,宋心红,林海燕,张冬芝,李向一,许艺博,王丽,薛付忠. 健康管理人群缺血性异常心电图的影响因素[J]. 山东大学学报(医学版), 2017, 55(6): 77-81. |
| [8] | 于媛媛,王春霞,苏萍,孙苑潆,薛付忠,刘言训. 健康管理队列白内障发病风险预测模型[J]. 山东大学学报(医学版), 2017, 55(6): 104-107. |
| [9] | 柳晓涓,蒋正,康凤玲,周苗,林伟强,薛付忠. 中性粒细胞计数与非酒精性脂肪肝关联性的前瞻性队列研究[J]. 山东大学学报(医学版), 2017, 55(6): 119-123. |
| [10] | 曹瑾,季晓康,孙秀彬,蒋正,薛付忠. γ-谷氨酰转肽酶与高尿酸血症关系的队列分析[J]. 山东大学学报(医学版), 2017, 55(6): 124-128. |
| [11] | 柳晓涓,丁荔洁,康凤玲,周苗,薛付忠. 健康管理人群支气管哮喘风险预测模型[J]. 山东大学学报 (医学版), 2017, 55(12): 56-61. |
| [12] | 顾建华,马晓天,李吉庆,薛付忠,王家林. 健康管理队列慢性阻塞性肺疾病风险预测模型[J]. 山东大学学报 (医学版), 2017, 55(12): 62-65. |
| [13] | 李倩,戴桃李,韩炜,郭成浩. 血管内皮细胞活化在感染后肠易激综合征发病机制中的作用[J]. 山东大学学报(医学版), 2016, 54(12): 58-61. |
| [14] | 刘言训, 刘佳, 张涛, 王璐, 薛付忠, 王萍. 基于纵向监测队列的2型糖尿病与甲状腺结节的关联性[J]. 山东大学学报(医学版), 2015, 53(8): 83-86. |
| [15] | 董艳艳,李延青,左秀丽,李长青. 山东某高校大学生肠易激综合征与功能性便秘的流行病学调查[J]. 山东大学学报(医学版), 2010, 48(6): 122-125. |
|